Medicare
Commenting today on the Medicare Payment Advisory Commission’s draft recommendations for 2020, AHA said it supports the recommendation to provide current law market-basket updates for the hospital inpatient and outpatient prospective payment systems.
The U.S. Supreme Court yesterday heard oral arguments in an appeal of a D.C. Circuit Court decision that the Department of Health and Human Services violated the Medicare Act when it changed Medicare’s reimbursement adjustment formula for disproportionate share hospitals without providing notice…
The Centers for Medicare & Medicaid Services recently finished mailing new Medicare cards to beneficiaries, which replace the Social Security-based number on their previous cards with a new Medicare beneficiary identifier.
On Dec. 21, the Centers for Medicare & Medicaid Services issued its final rule on the Medicare Shared Savings program (MSSP). The rule, called “Pathways to Success,” finalizes changes to the MSSP, including to the structure of payments made to accountable care organizations (ACOs) and other…
On January 11, the AHA held a webinar for members on the Centers for Medicare & Medicaid Services' December. 21, final rule that includes changes to the Medicare Shared Savings Program and to the structure of payments made to accountable care organizations and other aspects of participation in…
AHA outside counsel Sean Marotta shares insight from yesterday’s oral arguments before the Supreme Court in a case about when the Department of Health and Human Services must give public notice and accept and respond to comments on its proposed policies.
AHA letter to MedPAC regarding payment recommendations for 2020.
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Accountable care organizations interested in participating in the redesigned Medicare Shared Savings Program beginning July 1 must submit their notices of intent to apply by 12 p.m. ET on Jan. 18.
Medicare Part B suppliers may deliver the initial immunosuppressive drugs prescribed to a beneficiary after a transplant procedure to an address other than their home to ensure timely access to the medications at discharge.